Boyd Street Ventures news release announcing selection of James Spann as a member of the 2024 EY Entrepreneurs Access Network Cohort
Biotech firm aims to halt the progression of multiple sclerosis.
Innovator reduces blindness risk through a relationship-driven, intelligent eye care management platform.
Company addresses problem affecting millions of colonoscopies annually.
Read the November 2023 Newsletter from the Boyd Street Ventures team.
Exum is a scientific instrumentation company with innovative technology that significantly shortens development and discovery time for new materials,...
Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.
Funds will be used to invest in promising Oklahoma startups.
Two Black-led organizations partner to provide guidance and funding to BIPOC founders of promising businesses.
Preeminent bank lauds BSV for supporting underrepresented entrepreneurs in Oklahoma.
Leading regional bank applauds VC firm's efforts to support innovative founders struggling for funding.
VC firm's latest portfolio company conveniently delivers science-backed support to postpartum mothers.
We created the Boyd Street Endowment Fund to support businesses led by minorities, females and socially and economically disadvantaged individuals (SEDI).